Related Experiment Video
Updated: Aug 28, 2026

Perspectives on Neuroscience
Published on: July 31, 2007
On the Verge of the 3000th Publication: Reflections on Deceptions, Successes and Perspectives
1Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, B-3000 Leuven, Belgium.
Abstract:
A lifelong career devoted to the development of specific antiviral agents eventually yielded, besides (almost) 3000 publications, about ten antiviral compounds that were approved and marketed as antiviral drugs, i.e., DHPA (Duviragel®), BVDU (Zostex®, Mevir®, Brivir®…), VACV (Zelitrex®, Valtrex®), d4T (Stavudine®), emivirine (Coactinon®), rilpivirine (Edurant®), HPMPC (Vistide®), PMEA (Hepsera®), tenofovir (Viread®) and AMD-3100 (Mozobil®), with the latter as a hematopoietic stem cell mobilizer. The targeted viruses for these compounds were herpes simplex virus (HSV), varicella-zoster virus (VZV), cytomegalovirus (CMV), human immunodeficiency virus (HIV), and hepatitis B virus (HBV). For other viruses, such as filo-, rhabdo-, arena-, myxo-, polyoma- and papillomaviruses, strategies have been elaborated that should facilitate future developments of antiviral drugs.
Related Concept Videos
Introspection
Understanding Deception
Reflection of Waves
The Sense of Self: Reflected Self-Appraisal and Social Comparison
Hindsight Biases
Self-Evaluation: Self-Enhancement and Self-Verification
